THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — People who use a Peloton exercise bike at home should check their model number immediately. A recall of 2 million bikes with the model number PL01 was issued Thursday. People should stop using them immediately because of fall and injury hazards, the U.S.Continue Reading

WEDNESDAY, May 10, 2023 (HealthDay News) – The U.S. Drug Enforcement Administration on Wednesday issued a six-month extension for people seeking to fill controlled medication prescriptions via telehealth. That ability had been set to expire along with the ending of the pandemic public health emergency on May 11. “These medications,Continue Reading

WEDNESDAY, May 10, 2023 (HealthDay News) — Artificial intelligence (AI) research and development should stop until its use and technology are properly regulated, an international group of doctors and public health experts said. Certain types of AI pose an “existential threat to humanity,” the experts wrote in the May 9Continue Reading